Beneficiary Name : VANDANA NARESH GUNDETI

Contact No : 9271281924 Date Of Screening : 27/03/2025

Age (Yr) : 38 Gender : Female
Height (cm) : 158 Weight (Kg) : 60
Registration Number : 161400019226 Relation With Registered Worker : Self
Register Worker Name : Self
District : Solapur Taluka : Solapur north Pincode : 413005
Address : House No.,115/2 588shiraling Nagar Vidi Gharkul Solapur,Market Yard Solapur S.O,Solapur
North,Solapur,Maharashtra,413005

Blood Pressure :
Systolic : 119.00 (mmHg) Diastolic : 85.00 (mmHg)

Random Sugar : 99 mg/dL

Health History :
NIL

Pathology Investigation:
Sr No. Test Result
1 CBC, ESR, Malaria-Parasite Report Attached
2 LFT, KFT, Lipid Profile, Iron, Magnesium, RA, GGT Report Attached
3 Thyroid Profile, Vitamin B12 & D3, CEA Report Attached
4 HIV, HBV, HCV, VDRL Report Attached

Audiometry Test:
Right Ear : Normal Hearing Left Ear : Normal Hearing

Vision Test :
Right Eye Left Eye
Snellen Chart Reports : 6/6 6/6
Normal Vision Normal Vision
Near Vision : N6 N6
Observation : Normal Vision Normal Vision

CWH00008107818 D2D Camp / 355940 / 27 Mar 25 Page No - 1

 Lung Function Test : Test Result : NORMAL
FVC (Litre) FEV1 (Litre) FEV1/FVC (%)
1.62 1.57 96.91

Post Camp Recommendation :

1) Observation - Kindly consult a physician for further treatment.(OPD consultation) All reports are within acceptable
range. Kindly correlate clinically and follow-up

2) Clinical Recommendations - Normal

Dr. Krishnan Pillai

Registration No : 2020/03/1291

CWH00008107818 D2D Camp / 355940 / 27 Mar 25 Page No - 2

 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 29/03/2025 02:35 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Complete Blood Count

Investigation Result Units Biological Reference Interval

Hemoglobin (Hb) 11.5 gm/dl 12 - 15.0

Total RBC Count 4.81 Millions/Cumm 3.8 - 4.8

PCV 35.2 % 36 - 46
MCV 73.2 fL 83 - 101
MCH 23.9 Pg 27 - 32
MCHC 32.7 g/dL 31.5 - 34.5
RDW-CV 13.8 % 11.6 - 14.0
Total Leucocyte Count(TLC) 8290 Cells/Cumm 4000 - 10000
DIFFERENTIAL COUNT
Polymorphs 50 % 40 - 80
Lymphocytes 45 % 20 - 40
Monocytes 03 % 2 - 10
Eosinophils 02 % 1-6
Basophils 00 % 0-2
Platelet Count 3.45 Lakhs/Cumm 1.50 - 4.10

• Sample Type: EDTA Whole Blood.

• Method: Fully automated Hematology analyzer.

• Hb: Colorimetric method (surfactant method), Total WBC, RBC & Platelets: Electrical resistance (DynaHelix Flow technology,WBC
Diff count: Light scatter by laser (DynaScatter Laser technology)

• HCT,MCV,MCH, MCHC,RDW-CV calculated.

--End Of Report--

Dr. Sambhaji Pachkawade

MD Pathology
Processed At : Oppo labour court besides Alishan hotel, south sadar bazar rangbhavan area, solapur,
Maharashtra, Pin-413001
Page No - 3
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 29/03/2025 03:44 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Hematology
Investigation Result Units Biological Reference Interval

Erythrocyte Sedimentation Rate 08 mm/Hour 0 - 20

Malaria Parasite NEGATIVE
• Sample Type : EDTA Whole Blood.
• Method : Immunochromatography.

*Remark: It is a screening test. Negative result does not rule out possibility of Malaria.

--End Of Report--

Dr. Sambhaji Pachkawade

MD Pathology
Processed At : Oppo labour court besides Alishan hotel, south sadar bazar rangbhavan area, solapur,
Maharashtra, Pin-413001
Page No - 4
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 01/04/2025 11:22 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Liver Function Test

Investigation Result Units Biological Reference Interval

Serum Bilirubin, Total 0.3 mg/dL 0.2 - 1.2

• Sample Type : Serum.
• Method : Modified TAB method.
Serum Bilirubin, Direct 0.10 mg/dL 0 - 0.5
• Sample Type: Serum.
• Method: Diazo.
Serum Bilirubin, Indirect 0.20 mg/dL < 0.9
• Method: Calculated
Serum SGOT 9 U/L 5 - 34
• Sample Type: Serum.
• Method : IFCC
Serum SGPT 26 U/L 0 - 55
• Sample Type: Serum.
• Method : IFCC
Serum Alkaline Phosphatase 60 U/L 40 - 150
• Sample Type : Serum.
• Method : DGKC-SCE.
Serum Total Protein 7.4 g/dL 6.4 - 8.3
• Sample Type : Serum.
• Method: Direct Biuret Method.
Serum Albumin 4.3 g/dL 3.5 - 5.2
• Sample Type : Serum.
• Method: Bromocresol Green Method.
Serum Globulin 3.10 g/dL 2.0 - 3.5
• Method: Calculated.

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 5
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 01/04/2025 11:22 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Biochemistry
Investigation Result Units Biological Reference Interval

Serum Iron 27 µg/dL 50 - 170

• Sample Type: Serum
• Method: Chromazurol Method
Serum Magnesium 1.8 mg/dL 1.6 - 2.6
• Sample Type : Serum.
• Method : Xylidyl Blue with ATCS.
Serum Calcium 8.9 mg/dL 8.4 - 10.2
• Sample Type : Serum.
• Method: Arsenazo III Method, End point.
Gamma Glutamyl Transferase (GGT) 15 U/L 9 - 36
• Sample Type : Serum.
• Method : Szasz Methodology.
Rheumatoid Factor (RA) 2.00 IU/mL

Sample Type: Serum

Method: Latex enhanced Immunoturbidimetry

• Interpretations: Rheumatoid Factor (RF) is an autoantibody against human IgG commonly seen in sera of patients with
rheumatoid arthritis. The measurement of RF value is useful in evaluating the diagnosis, effects of therapy, and prognosis of RA,
systemic lupus erythematosus, chronic hepatopathy, etc.

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 6
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 01/04/2025 11:22 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Renal Function Test

Investigation Result Units Biological Reference Interval

Serum Blood Urea 23.54 mg/dL 7 - 18.7

• Sample Type: Serum
• Method: UREASE/GLDH methodology.
BUN-Blood Urea Nitrogen 10.99 mg/dL 9-23
• Method: Calculated.
Serum Creatinine 0.61 mg/dL 0.57 - 1.11
• Sample Type : Serum.
• Method : Modified Jaffes Method.
Serum Uric Acid 3.1 mg/dL 2.6 - 6
• Sample Type : Serum.
• Method: Uricase-PAP Method

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 7
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 01/04/2025 11:22 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Lipid Profile
Investigation Result Units Biological Reference Interval

Serum Total Cholesterol 154 mg/dL Desirable < 200

Borderline High 200 - 239
High >= 240
• Sample Type : Serum.
• Method : CHOD-PAP Methodlogy.
Serum Triglycerides 144.31 mg/dL 40 - 140
• Sample Type : Serum.
• Method: GPO-TOPS Methodology.
Serum VLDL-Cholesterol 28.86 mg/dl 10.0 - 35.0
• Method: Calculated.
Serum HDL-Cholesterol 42.8 mg/dL Major Risk <40
Negative Risk <60

• Sample Type: Serum.

• Method: Selective Inhibition Method
LDL Cholesterol 82.34 mg/dL Desirable < 130
Borderline 130-159
High Risk for CHD > 160
• Sample Type : Serum
• Method : Selective Solubilisation Method

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 8
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 02/04/2025 07:53 am
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Thyroid Function Test

Investigation Result Units Biological Reference Interval

Serum T3 0.83 ng/mL 0.87 - 1.78

Serum T4 7.30 ng/mL 6.09 - 12.23
Serum TSH 2.38 uiu/mL 0.5 - 6.3
• Sample Type: Serum.
• Method: CLIA.

Interpretation:
1) In pregnancy there is an alteration in thyroid hormone production and metabolism.
2) Useful for screening of thyroid illness, primary/secondary hypo-or hyperthyroidism, and also for monitoring patients with thyroid
replacement therapy.

• Please correlate with clinical conditions.

*References from Wallach’s Interpretation of Diagnostic Tests. (10th edition).

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 9
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 02/04/2025 07:53 am
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Immunoassay
Investigation Result Units Biological Reference Interval

Vitamin B12 (Cyanocobalamin) 230.00 pg/mL 180 - 914

Deficient<145
• Sample Type: Serum
• Method: CLIA.

• Comments: Vitamin B12 performs many important functions in the body, but the most significant function is to act as a coenzyme
for reducing ribonucleotides to deoxyribonucleotides, a step in the formation of genes.

• Decreased Levels:
1. Lack of Intrinsic factor: Total or partial gastrostomy, Atrophic gastritis, Intrinsic factor antibodies.
2. Malabsorption: Regional ileitis, resected bowel, Tropical Sprue, Celiac disease, pancreatic insufficiency, bacterial overgrowth &
achlorhydria.

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 10
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 02/04/2025 07:53 am
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Immunoassay
Investigation Result Units Biological Reference Interval

Vitamin-D (Total) 18.11 ng/mL Deficiency <10

Insufficiency 10-30
Sufficiency 30-100
Toxicity >100
• Sample type: Serum
• Method: CLIA.

• Interpretation:
[Link] D is a lipid-soluble steroid hormone that is produced in the skin through the action of sunlight or is obtained from dietary
sources.
[Link] D inadequacy may lead to secondary hyperparathyroidism, increased bone turnover, and progressive bone loss, increasing
the risk of osteoporosis.
[Link] have associated vitamin D deficiency with an increased risk of cancer, autoimmune disease, infectious diseases,
cardiovascular diseases, and many chronic diseases.

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 11
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 02/04/2025 07:44 am
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Immunoassay
Investigation Result Units Biological Reference Interval

Cancer & Tumor Marker - CEA 1.32 ng/ml Non Smoker <2.5
Smoker >5.0
• Sample Type: Serum.
• Method: ECLIA.

• Interpretation:
[Link] antigen (CEA) is an oncofetal glycoprotein that is normally expressed by mucosal cells. It is overexpressed by a
variety of malignancies. Although it is most commonly associated with colorectal cancer.
[Link] can also be elevated in other malignancies such as breast, liver, stomach, and pancreas.
[Link] are a number of benign conditions that may lead to elevations in serum CEA level including cigarette smoking,
pancreatitis, biliary obstruction, peptic ulcer disease, and hypothyroidism, but the extent of elevation is substantially less, and it is
rare to see an elevation of >10 ng/ml in this context.
[Link] is not an effective marker for hidden (occult) malignancy, since early tumors do not cause significant blood elevation.
5.A single test is difficult to evaluate but the number of tests done weeks apart show the trend in disease progression or regression.
[Link] important clinical application of CEA is its prognostic significance with colorectal cancer and its metastasis.

• Please correlate with clinical conditions.

--End Of Report--

Dr. Sharvari Vishwasrao

[Link]
Processed At : Navkar Avenue 1st flower,[Link].5,NDA Road,Bavdan,Pune,Maharashtra 411021
Page No - 12
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 29/03/2025 05:54 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Serology
Investigation Result

HIV Rapid Test NON REACTIVE

• Sample Type: Serum
• Method: Immunochromatography.

• Clinical Significance: Human Immunodeficiency virus (HIV) testing determines whether you're infected with HIV, a virus that
weakens the immune system and can lead to AIDS.

• Note: It is a screening test, some serum components as well as other conditions may show cross-reactivity with HIV antibodies.
.

--End Of Report--

Dr. Sambhaji Pachkawade

MD Pathology
Processed At : Oppo labour court besides Alishan hotel, south sadar bazar rangbhavan area, solapur,
Maharashtra, Pin-413001
Page No - 13
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 29/03/2025 05:54 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Serology
Investigation Result

HBsAg (Hepatitis B antigen) test NON REACTIVE

• Sample Type: Serum
• Method: Rapid Immunochromatography.
• Kindly note this is a screening test. Kindly confirm this result by ELISA method.

• Clinical Significance: This assay is useful for the diagnosis of acute, recent and chronic HBV infection. It also determines the
chronic Hepatitis B infection status. It is the first serologic marker to appear in the serum at 6 to 16 weeks following exposure to
HBV. It usually disappears1 to 2 months after the onset of symptoms. Persistence >6 months indicates chronic carrier state or
chronic HBV infection.

• Please correlate with clinical conditions.

--End Of Report--

Dr. Sambhaji Pachkawade

MD Pathology
Processed At : Oppo labour court besides Alishan hotel, south sadar bazar rangbhavan area, solapur,
Maharashtra, Pin-413001
Page No - 14
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 29/03/2025 05:54 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Serology
Investigation Result

HCV-Rapid Test NON REACTIVE

• Sample Type: Serum.
• Method: Immunochromatography.

• Clinical Significance: Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). The patient may develop liver cirrhosis
and/or liver cancer in severe infections. It is transmitted primarily through transfusion of infected blood, sharing of infected
needles, and through sexual transmission.

• Note: It is a screening test, Patient's having auto-immune liver diseases may give false positive results.

--End Of Report--

Dr. Sambhaji Pachkawade

MD Pathology
Processed At : Oppo labour court besides Alishan hotel, south sadar bazar rangbhavan area, solapur,
Maharashtra, Pin-413001
Page No - 15
 Patient Name : VANDANA NARESH GUNDETI Registered On : 27/03/2025 01:48 pm
Patient Id : CWH00008107818 Reported On : 29/03/2025 05:54 pm
Age/Gender : 38Y/FEMALE Customer Name : MBOCWWB

Serology
Investigation Result

VDRL Rapid Test NON REACTIVE

• Sample Type : Serum.
• Method : Immunochromatography.

• Clinical Significance : Rapid Syphilis Antibody test is an immunoassay for the rapid and visual detection of antibodies to
Treponema Pallidum in human serum or plasma to aid in the diagnosis of Syphilis.

• Limitations : The test provides the presumptive diagnosis of Syphilis. A confirmed Syphilis diagnosis should only be made
by a physician after all clinical and laboratory findings have been evaluated.

• It is a screening tests, kindly correlate further with confirmatory tests in consultation with doctor.

--End Of Report--

Dr. Sambhaji Pachkawade

MD Pathology
Processed At : Oppo labour court besides Alishan hotel, south sadar bazar rangbhavan area, solapur,
Maharashtra, Pin-413001
Page No - 16